Biovie (BIVI) Net Equity Issued and Repurchased (2016 - 2025)

Biovie has reported Net Equity Issued and Repurchased for 10 years, with the latest figure at $10.5 million in Q3 2025.

• Quarterly Net Equity Issued and Repurchased rose 362.92% year-over-year to $10.5 million in Q3 2025, while the trailing twelve-month figure through Mar 2026 was $10.5 million (down 33.28% YoY) and the FY2025 annual result came in at $15.7 million, down 43.62% from the prior year.
• Net Equity Issued and Repurchased declined to $10.5 million in Q3 2025 per BIVI's latest filing, from $13.4 million in the prior quarter.
• Over five years, Net Equity Issued and Repurchased peaked at $32.5 million in Q4 2022 and troughed at $1.3 million in Q2 2023.
• A 5-year average of $12.2 million and a median of $10.5 million in 2025 frame the typical range for Net Equity Issued and Repurchased.
• The sharpest annual moves came in 2023 and 2025: Net Equity Issued and Repurchased plunged 89.7% in 2023, then jumped 362.92% in 2025.
• Over 5 years, Net Equity Issued and Repurchased stood at $18.5 million in 2021, then surged by 75.7% to $32.5 million in 2022, then sank by 77.18% to $7.4 million in 2023, then surged by 80.76% to $13.4 million in 2024, then declined by 22.05% to $10.5 million in 2025.
• According to Business Quant data, Net Equity Issued and Repurchased over the past three periods registered $10.5 million, $13.4 million, and $2.3 million for Q3 2025, Q4 2024, and Q3 2024 respectively.